Harvard Bioscience Inc (HBIO)
3.85
+0.03
(+0.79%)
USD |
NASDAQ |
May 03, 16:00
3.89
+0.04
(+1.04%)
After-Hours: 20:00
Harvard Bioscience Cash and Short Term Investments (Quarterly): 4.283M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.283M |
September 30, 2023 | 5.34M |
June 30, 2023 | 4.324M |
March 31, 2023 | 3.789M |
December 31, 2022 | 4.508M |
September 30, 2022 | 5.144M |
June 30, 2022 | 4.259M |
March 31, 2022 | 5.433M |
December 31, 2021 | 7.821M |
September 30, 2021 | 5.548M |
June 30, 2021 | 6.237M |
March 31, 2021 | 5.815M |
December 31, 2020 | 8.317M |
September 30, 2020 | 2.806M |
June 30, 2020 | 2.629M |
March 31, 2020 | 5.882M |
December 31, 2019 | 8.335M |
September 30, 2019 | 6.845M |
June 30, 2019 | 4.934M |
March 31, 2019 | 5.03M |
December 31, 2018 | 8.173M |
September 30, 2018 | 6.661M |
June 30, 2018 | 5.624M |
March 31, 2018 | 5.991M |
December 31, 2017 | 5.192M |
Date | Value |
---|---|
September 30, 2017 | 5.836M |
June 30, 2017 | 4.724M |
March 31, 2017 | 4.599M |
December 31, 2016 | 5.596M |
September 30, 2016 | 5.345M |
June 30, 2016 | 3.631M |
March 31, 2016 | 4.175M |
December 31, 2015 | 6.744M |
September 30, 2015 | 6.09M |
June 30, 2015 | 7.402M |
March 31, 2015 | 8.031M |
December 31, 2014 | 14.13M |
September 30, 2014 | 26.73M |
June 30, 2014 | 26.43M |
March 31, 2014 | 25.84M |
December 31, 2013 | 25.77M |
September 30, 2013 | 36.93M |
June 30, 2013 | 34.10M |
March 31, 2013 | 23.75M |
December 31, 2012 | 20.68M |
September 30, 2012 | 20.28M |
June 30, 2012 | 18.66M |
March 31, 2012 | 17.24M |
December 31, 2011 | 17.92M |
September 30, 2011 | 16.24M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
2.629M
Minimum
Jun 2020
8.335M
Maximum
Dec 2019
5.382M
Average
5.34M
Median
Sep 2023
Cash and Short Term Investments (Quarterly) Benchmarks
Bruker Corp | 340.10M |
Azenta Inc | 984.14M |
Bionano Genomics Inc | 101.89M |
Akoya Biosciences Inc | 83.12M |
Singular Genomics Systems Inc | 173.94M |